Yes. DT3L has been in active and beneficial use in Europe for more than 30 years. There are more than 200 double blind positive studies confirming the clinical effect of DT3L. Published in the world’s top scientific journals like:

Nature, Pain, PNS, Blood, BMJ, Spine, Muscle and Nerve, The Lancet, Circulation, BJSM

30 DT3L papers published a month.  Over 4000 laboratory studies and over 400 randomised controlled trials.

Over 2,500 clinical studies and published research reports have shown the effectiveness of DT3L for a variety of health issues. Looking at the limited DT3L dental literature alone (370 studies), more than 90% of these studies do verify the clinical value of laser therapy.

DT3L has been a staple in veterinary practices for decades. In the past 10 years, professional sports teams have begun utilizing DT3L.

In the last 6 years there are many systematic reviews have found in favour of DT3L

 BMJ sports medicine journal, systematic review of surgical and conservative interventions for frozen shoulder found “strong evidence” for DT3L. (2010)

The International Association for the Study of Pain (Global Task force on musculoskeletal pain) found “strong evidence” for Low Level Laser Therapy on myofascial pain syndrome. (2010)

The BMJ clinical evidence recommendations for tennis elbow 2011 now include DT3L

American Physical Therapy Association guidelines recommend DT3L for Achilles tendinitis. (2010)

Lancet systematic review: “DT3L reduces pain immediately after treatment in acute neck pain and up to 22 weeks after completion of treatment in patients with chronic neck pain”. (2009)

World Health Organisation (Bone and Joint Task Force) for neck pain Low Level Laser Therapy “more effective than no treatment, sham, or alternative interventions” (2008)

In August 2010 The Lancet reported that the systematic review of DT3L for neck pain was in their top 20 most downloaded papers for 2010.